Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
3.430
+0.250 (7.86%)
At close: Jun 26, 2026, 4:00 PM EDT
3.420
-0.010 (-0.29%)
After-hours: Jun 26, 2026, 7:08 PM EDT
Prime Medicine Employees
Prime Medicine had 146 employees as of December 31, 2025. The number of employees decreased by 68 or -31.78% compared to the previous year.
Employees
146
Change (1Y)
-68
Growth (1Y)
-31.78%
Revenue / Employee
$27,630
Profits / Employee
-$1,358,726
Market Cap
619.52M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 146 | -68 | -31.78% |
| Dec 31, 2024 | 214 | -20 | -8.55% |
| Dec 31, 2023 | 234 | 59 | 33.71% |
| Dec 31, 2022 | 175 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| 4D Molecular Therapeutics | 196 |
| CorMedix | 191 |
| Omeros | 175 |
| BridgeBio Oncology Therapeutics | 106 |
| Tectonic Therapeutic | 60 |
| Crescent Biopharma | 55 |
| Faeth Therapeutics | 29 |
| Achieve Life Sciences | 28 |
PRME News
- 4 days ago - Prime Medicine granted RMAT designation for PM359 - TheFly
- 4 days ago - Prime Medicine Receives U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for PM359 for the Treatment of Chronic Granulomatous Disease (CGD) - GlobeNewsWire
- 8 days ago - Prime Medicine announces New Zealand cleared trial application for PM577a - TheFly
- 8 days ago - Prime Medicine Announces New Zealand Clearance of Clinical Trial Application for PM577a in H1069Q-mutated Wilson Disease - GlobeNewsWire
- 16 days ago - Prime Medicine Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 21 days ago - Prime Medicine Transcript: AGM 2026 - Transcripts
- 22 days ago - Prime Medicine Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 23 days ago - Prime Medicine to Present at Goldman Sachs 47th Annual Global Healthcare Conference - GlobeNewsWire